 the International Carotid Stenting Study
Trial (ICST),10 which enrolled 1713 patients, demonstrated an increased stroke risk for CAS (7.7%) compared
with CEA (4.1%) in neurologically symptomatic patients.
This observed difference was significant (P ⫽ .002). The
rate of any stroke or death ⱕ30 days of treatment in the
stenting group was more than twice the rate the rate